Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women

Background. Cervical cancer is a major public health problem for women in sub-Saharan Africa. Availability of a human papillomavirus (HPV) vaccine could have an important public health impact. Methods. In this phase IIIb, double-blind, randomized, placebo-controlled, multicenter trial (NCT00481767),...

Descripción completa

Detalles Bibliográficos
Autores principales: Sow, Papa Salif, Watson-Jones, Deborah, Kiviat, Nancy, Changalucha, John, Mbaye, Khardiata Diallo, Brown, Joelle, Bousso, Kouro, Kavishe, Bazil, Andreasen, Aura, Toure, Macoumba, Kapiga, Saidi, Mayaud, Philippe, Hayes, Richard, Lebacq, Marie, Herazeh, Marjan, Thomas, Florence, Descamps, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636781/
https://www.ncbi.nlm.nih.gov/pubmed/23242542
http://dx.doi.org/10.1093/infdis/jis619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636781/
https://www.ncbi.nlm.nih.gov/pubmed/23242542
http://dx.doi.org/10.1093/infdis/jis619

Ejemplares similares